Lupron Depot
Coverage of Lupron Depot in the Nexus archive.
- Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
The Trump administration proposes a rule to prevent hospitals in the 340B program from charging markups on discounted drugs for Medicare patients, estimating $1.1 billion in annual savings. The rule aims to change reimbursement formulas to reduce patient costs, but the American Hospital Association warns it could strain hospital finances and access to care.
- Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
The Trump administration proposes a rule to prevent hospitals in the 340B program from charging markups on discounted drugs for Medicare patients, aiming to save $1.1 billion annually. The rule would reduce Medicare reimbursements for these hospitals by approximately 40%, targeting cost savings for patients while raising concerns about potential revenue losses for hospital systems.
- Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
The Trump administration proposes a rule to prevent hospitals in the 340B program from charging markups on discounted drugs for Medicare patients, aiming to save $1.1 billion annually. The rule would adjust Medicare reimbursement formulas for these hospitals, with an example showing potential savings on the prostate cancer drug Lupron Depot.